| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 41.96B | 43.13B | 41.53B | 39.63B | 37.25B | 29.61B |
| Gross Profit | 12.71B | 13.69B | 12.96B | 12.02B | 9.81B | 7.61B |
| EBITDA | 9.48B | 10.34B | 9.72B | 8.85B | 6.69B | 4.88B |
| Net Income | 5.65B | 6.83B | 7.50B | 7.25B | 5.49B | 3.43B |
Balance Sheet | ||||||
| Total Assets | 94.66B | 95.19B | 89.51B | 79.19B | 76.21B | 68.65B |
| Cash, Cash Equivalents and Short-Term Investments | 47.45B | 49.04B | 51.06B | 45.88B | 43.66B | 41.19B |
| Total Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Liabilities | 13.13B | 13.82B | 14.17B | 12.72B | 12.81B | 10.30B |
| Stockholders Equity | 79.65B | 79.40B | 73.36B | 64.69B | 63.24B | 58.20B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 6.59B | 6.31B | 4.98B | 3.87B | 4.25B |
| Operating Cash Flow | 0.00 | 7.77B | 7.37B | 5.42B | 4.33B | 5.04B |
| Investing Cash Flow | 0.00 | -9.14B | -17.87B | 144.00M | -685.00M | -764.00M |
| Financing Cash Flow | 0.00 | -1.16B | -1.02B | -5.93B | -983.00M | -987.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | ¥66.75B | 6.19 | ― | 2.03% | -4.42% | 10.23% | |
80 Outperform | ¥79.53B | 11.63 | 15.07% | 1.74% | 15.12% | 40.72% | |
80 Outperform | ¥21.94B | 9.84 | ― | 1.82% | -7.26% | ― | |
75 Outperform | ¥54.38B | 16.36 | ― | 2.92% | 3.03% | 28.27% | |
73 Outperform | ¥59.22B | 18.37 | 6.31% | 4.01% | 6.38% | 22.81% | |
73 Outperform | ¥5.36B | 10.80 | ― | 2.49% | 9.77% | -7.98% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |